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Organization of this progress report
The present report begins with a statement of the overall goal of the project and
a summary list of the specific hypotheses to be tested. These are followed by sections
on results, conclusions, significance and plans for the next year.
Notice of approval of funding for this project was received in December, 1994.
However, the official funding notice was received in May, 1995. Thus, the Principal
Investigator requested a project start date of February 1, 1995 in order to cover the
costs of fabricating harnesses and cages for the hindlimb unweighted rats. The
Research Associate was hired in June, 1995, after receipt of the official funding notice,
and the first experiments were performed in July, 1995. Thus, the present progress
report presents results obtained over the four months of July through October, 1995.
Overall Goal
The overall goal of the project is to characterize the effects of simulated
microgravity on vascular function. Microgravity is simulated using the hindlimb
unweighted (HU) rat, and the following vessels are removed from HU and paired
control rats for in vitro analysis: abdominal aorta, carotid and femoral arteries, jugular
and femoral veins. These vessels are cut into 3 mm long rings and mounted in tissue
baths for the measurement of either isometric contraction, or relaxation of pro-
contracted vessels. The isolated mesenteric vascular bed is perfused for the
measurement of changes in perfusion pressure as an index of arteriolar constriction or
dilation.
Hypotheses
The following hypotheses were based on the observations of Delp and
coworkers (1993), who found that the abdominal and thoracic aortas from HU rats
exhibited decreased maximal responses to vasoconstrictor agonists and no change in
vasodilator mechanisms, compared to tissues from control rats.
j_. HU Treatment decreases both maximal contractility and
sensitivity to vasoconstrictor agonists. Experiments to date address this
hypothesis. Both norepinephrine and serotonin have been tested. The testing is
complete in Sprague-Dawley and Wister rats at 20 day HU treatment. In addition, the
vasoconstrictor effects of angiotensin II, endothelin and CaCI z (in K_ depolarized
vessels) will be assessed to complete the testing of hypothesis I.
The following are the remaining hypotheses to be addressed:
J:_. Isolated blood vessels from HU rats will exhibit a
generalized decrease in responsiveness to neurogenic stimulation, due
to both presynaptic and postsynaptic mechanisms. Contractile responses to
nerve terminal selective, electrical field stimulation will be measured. Ring segments
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of the caudal artery will be studied for contractile responses to adrenergic nerve
stimulation while the jugular vein will be studied for dilator responses to adrenergic
nerve stimulation mediated by 8-adrenergic receptors. The isolated perfused
mesenteric vascu!ar bed will enable us to study responses of vasodilator, capsaicin-
sensitive sensory nerves.
J:J.y.._t_g_LW. Both endothellum-dependent and independent vasodilation
are not altered by HU treatment. Vasodilator responses will be characterized in
perfused caudal and carotid arteries and the perfused mesenteric bed. Vasodilator
agents will include acetylcholine (endothelium-dependent) and sodium nitroprusside
and CGRP (endothelium-independent). The responses of isolated rings of jugular
vein to isoproterenol, a I]-adrenergic agonist, will also be assessed.
_yg..QL_,.,_J2. HU-induced changes in vascular function follow the same
time course for development and recovery that is found for skeletal
muscle. Once the above studies have been completed, the time course for the
appearance and recovery of identified changes in vascular function will be
determined. 5 and 10 day HU rats will be analyzed because these treatment times
were shown to be early and intermediate with respect to hindlimb skeletal muscle
alterations. 20 and 28 day HU rats will be compared to determine if the maximal
effects have been achieved. Recovery of normal vascular function will be assessed in
rats taken 7, 14, 21 and 28 days following termination of a 20 day HU treatment.
Modifications to the original proposal
The following parameters were not proposed in the original grant submission,
but were subsequently added for the reasons given:
1) The abdominal aorta was added to allow comparison of results with those
published by Delp et al. (1993).
2) Fourteen day HU treatment was added because this duration was used by Delp
et al. (1993). '
3) The Wistar strain of rats was added for comparison of results with Sprague-
Dawley rats. Initial studies with femoral artery yielded no effect of 20 day HU
treatment. Thus, Wistar was added to determine if the lack of treatment effect was due
to the strain of rat.
Results
Statistical analysis. Comparisons of mean contractile responses to 68 mM K÷ in
vessels from control versus HU treated rats were made using one-way ANOVA. HU
treatment effect on full concentration response curves to either norepinephrine or
serotonin were assessed using two-way repeated measures ANOVA. Both ANOVA
assessments were followed by posthoc analysis with a Scheffe's Test. P<0.05 was the
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criterion for significant differences and the reported N values indicate the number of
experiments. Each experiment included 2-4 vascular rings per treatment.
Ootimizatio, Jof restina force. All vessels studied were mounted in tissue baths
for the measurement of isometric contraction. In the initial experiments, optimal resting
forces were determined. The optimal resting force is the magnitude of stable pre-
stretch that yields the maximal development of tone in response to vasoconstrictor
stimulus. Arteries and veins were initially adjusted to resting forces of 0.5 and 0.2 g,
• respectively. After 30 minutes, tissues were exposed to Krebs' solution containing 68
mM K÷to depolarize tissues and elicit a contraction. After steady-state contraction was
achieved, tissue baths were drained and refilled twice with normal Krebs' solution (4.9
mM K÷) and allowed to relax to resting force. The resting force was increased
incrementally by 0.25-0.5 and 0.1-0.2 g in arteries and veins, respectively, and vessels
were exposed to 68 mM K" at each increment at 30 minute intervals. The following are
the optimal resting forces in the respective blood vessels:
Vessel ring
abdominal aorta
from Control Rats
(g)
2
from HU (20-day)
(g)
2
femoral artery 1 1
carotid artery 1.5 1
0.6 0.6
1 0.6
femoral vein
jugular vein
The isolated mesenteric vascular beds from both control and HU rats were
per/used at 4 ml/minute. This yielded unstimulated per/usion pressures of 28-30 mm
Hg in both control and treated vascular beds. This suggests that there was no
difference between the beds in the resting level of resistance to flow.
All blood vessel rings are exposed to 68 mM K" twice with a 30 minute interval
between. Subsequently vessels are then contracted by cumulative addition of either
norepinephrine or serotonin. The second and a_l subsequent exposures to potassium
have been found to generate uniform contractile responses. Thus, vessels from both
control and HU treated rats were compared on the basis of the second potassium
response, and the results are shown in figures 1-5. As shown in figure 1, the K÷-
induced contraction of abdominal aorta rings from HU rats was less than that from
control animals. The difference was greatest, and was statistically significant, in
tissues from Wistar compared to Sprague Dawley rats.
S/m/tar resuRs were obtained in both carotid and femoral artery rings as shown
in figures 2 and 3. Again, the W-induced contraction was less in artery rings from HU
treated Sprague Dawley and Wistar rats. The only exception was the femoral artery
from Sprague Dawley rats in which HU treatment produced no difference from control.
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In contrast to artery rings, 20-day HU treatment tended to produce an increased
contraction to 68 mM K* compared to control (figures 2 and 3). This trend became
significant in the case of jugular veins from Wistar rats (figure 3). One exception to this
trend was the femoral veins from Wistar rats in which HU treatment produced no
difference from control.
The effect of 68 mM K÷exposure was also analyzed in 14 day HU treated rats
and their paired controls, and the results are shown in figures 4 and 5. No significant
differences between HU and control vessels were observed. However, certain of the
trends seen with 20 day HU treatment were apparent. Namely, HU treatment tended
to reduce the magnitude of contraction in the arteries and to increase the magnitude of
contraction in the veins. Insufficient numbers of experiments have been conducted to
date to allow the formulation of conclusions. Time course experiments will be included
in the second year of the project.
Studies of the effects of 20 day HU treatment on arterial and venous responses
to norepinephrine were carried out and the results are shown in figures 6-10. As
shown in figure 6, abdominal aorta rings from 20 day HU treated rats exhibited lower
maximal responses to norepinephrine than control, but no difference in sensitivity was
seen. The magnitude of this difference was greater in vessels from Wistar rats,
consistent with the greater and significant difference observed in the contraction to 68
mM K*.
Similar results were obtained in both carotid and femoral arteries. As shown in
figures 7 and 8, 20 day HU treatment caused a significant reduction in the maximal
response to norepinephrine compared to control. The one exception was in the case
of femoral arteries from Sprague Dawley rats (figure 8). 20 day HU treatment did not
produce a difference in contractile response to norepinephrine compared to control.
This is consistent with the failure of 20 day HU treatment to produce a difference in
contractile response to 68 mM K_ compared to control. The effect of 20 day HU
treatment on the response of veins to norepinephrine was studied and the results are
shown in figures 9 and 10. No significant differences were found between HU treated
and control in either jugular or femoral vein from either Sprague Dawley or Wistar rats.
However, in contrast to arteries, there was a consistent trend toward greater maximal
response in veins from HU treated rats compared to control.
A confounding factor may account for the lack of a significant effect of 20 day
HU treatment in veins, at least in the case of the jugular vein. This vessel has been
shown to have a predominance of beta over alpha adrenergic receptors (Cohen and
Wiley, 1978). Thus, the magnitude of contraction to norepinephrine tended to be small
and was followed at higher concentrations by relaxation. These experiments in both
the jugular and femoral veins will be repeated in the presence of beta receptor
antagonists to more fully assess alpha adrenergic receptor mediated contraction.
Contractions to norepinephrine were also assessed in vessels from 14 day
hindlimb unweighted rats and their paired controls, and the results are shown in
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figures 11 through 14. The number of experiments is small and more experiments will
be conducted. Nevertheless, 14 day HU treatment produced a significant reduction in
the maximal response to norepinephrine compared to control in vessels from Sprague
Dawley rats. In centrast, no significant effects of 14 day HU treatment were seen in
carotid arteries from Wistar rats or in femoral arteries from either strain. Similar studies
in jugular and femoral vein are shown in figures 13 and 14. Again, 14 day HU
treatment had no effect on venous contraction to norepinephrine compared to control.
The effects of perfusion of the isolated mesenteric vascular bed with 68 mM K*
followed after washout by cumulative increase in norepinephrine in the perfusate were
studied and the results are shown in figure 15. Perfusion with both 68 mM K* and
norepinephdne increased perfusion pressure. However, HU treatment had no
significant effect compared to control. This vascular preparation ruptures at perfusion
pressures above 150 mm Hg. thus, maximal response cannot be determined. The
present results demonstrate that HU treatment does not alter the sensitivity of the
isolated mesenteric vascular bed to either 68 mM K* or norepinephrine.
The effect of 20 day HU treatment on arterial and venous ring response to
serotonin was determined and the results are shown in figures 16 and 17. No
significant differences were found between vessels from HU treated and control
animals. In part, this may result from the small number of experiments conducted to
date. Additional experiments are planned. However, it is of interest that in the case of
the jugular vein, serotonin elicited a substantially stronger contraction in veins from 20
day HU treated animals compared to control. Additional experiments will reveal
whether this trend achieves significance. This result is consistent with the effects of
HU treatment on the venous contractile response to both 68 mM K÷ and
norepinephrine, namely, the trend is toward a greater magnitude of contraction in
veins from HU treated rats.
Conclusions
The strongest results were observed after 20 day HU treatment. 14 day HU
treatment may be insufficient to yield full effect. Alternatively, insufficient numbers of
experiments have been conducted to date with the 14 day HU treated animals to allow
inte rpret ati on.
There was a consistent finding among the arteries studied. Namely, HU
treatment depressed the magnitude of maximal contraction compared to control in the
case of both 68 mM K* and norepinephrine. The one exception to this pattem was in
the case of femoral arteries from Sprague Dawley rats. 20 day HU treatment had no
effect on contraction regardless of the stimulus used. In the case of the jugular and
femoral veins, 20 day HU treatment either had no effect or, in the case of the jugular
vein from Wistar rats, significantly increased the maximal contractile response to
potassium compared to control. In addition, while the effect of HU treatment was not
significant, there was a trend toward enhancement of contraction by HU treatment.
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Further experiments will be required to clarify the effect of HU treatment on contractile
response of veins.
Significance
In general, HU treatment decreased the maximal contractile capacity of arterial
smooth muscle, but tended to have no effect or to increase the maximal contractile
capacity of venous smooth muscle. In order to understand the significance of these
results, one must first address the extent to which HU treatment simulates microgravity.
As summarized by Delp et al. (1993) HU treatment of rats mimics many of the changes
in fluid distribution and cardiovascular function seen in humans subjected to
prolonged head-down tilt or spaceflight. These include increased central venous
pressure, reduced blood volume, tachycardia and decreased exercise capacity. In
further support, Soyet and coworkers (1995) found that both spaceflight and HU
treatment decreased the vasoconstrictor sensitivity of rat vena cava to norepinephrine
by a protein kinase C-dependent mechanism. In contrast, Fagette and coworkers
.(1995) found no effect of 14 day HU treatment on blood pressure, heart rate or
baroreceptor reflex sensitivity. These authors found no evidence for orthostatic
intolerance. Taking the results of these three studies together, it can be tentatively
concluded that HU treatment simulates many but not all of the effects of microgravity.
Namely, HU treatment may simulate the effects of microgravity on volume distribution
and vascular contractility, but not baroreceptor function. Confirmation of this proposal
awaits direct testing of hemodynamic and vascular parameters in rats subjected to
space flight.
If it is accepted that HU treatment mimics at least some aspects of the
cardiovascular effects of spaceflight, the present results suggest a contribution of
altered vascular function to microgravity-induced cardiovascular deconditioning. An
impaired capacity of the arterial circuit to contract would pass the pressure-head to the
venous circuit, contributing to elevated venous pressure. The enhanced capacity of
veins to contract in the presence of vasoconstrictor agents might also contribute to
elevated venous pressure. If these vascular changes occur in humans, they are likely
to contribute to postural intolerance. Namely, exposure to gravity in the standing
position in a spaceflight-adapted human may trigger sympathetic stimulation of the
vasculature. However, the reduced capacity for arterial constriction would yield a
reduced peripheral resistance and, therefore, a lowered blood pressure.
It is of particular significance that HU treatment had different effects on arterial
and venous vasoconstrictor mechanisms. This suggests that HU treatment itself, and
not some nonspecific factor such as stress, was responsible for the observed effects.
Further studies to characterize the mechanisms underlying the effects of HU on arterial
and venous function are clearly warranted and will be the subject of the two remaining
years of this project.
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Plans for the next year
In order to complete the testing of Hypothesis I, contractile responses to K* (10-
100 mM), serotor',',_, angiotensin II, endothelin and Ca" in K+-depolarized vessels will
be determined in arteries and veins from control and HU treated rats. Selection of
strain will be based on which strain yielded the greatest HU treatment effect in each
blood vessel. In addition, norepinephrine-induced contractions in jugular and femoral
veins will be assessed under conditions allowing unopposed alpha adrenoceptor
stimulation: in the presence of agents that block beta adrenoceptors, neuronal and
extraneuronal catecholamine uptake, nitric oxide synthase and cyclooxygenase.
Experiments will also be conducted to assess vascular responsiveness to
neurogenic stimulation using rings of caudal artery, jugular vein and isolated perfused
mesenteric vascular bed (Hypothesis II). Vasodilator responses will be assessed in
perfused caudal and carotid arteries and perfused mesenteric bed as well as jugular
vein rings (Hypothesis III). Both endothelium dependent and independent
vasodilation will be characterized.
The most salient effects of HU treatment identified by the studies described
above will be chosen for analysis of the time course of HU effect. Five and 10 day HU
treatment will be assessed. In addition, recovery of normal vascular function will be
assessed in rats taken 7, 14, 21 and 28 days following termination of 20 day HU
treatment.
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Figure 1:
Vascular contractile responses to 68mM potassium in abdominal aortas from control
and twenty-day hindlimb unweighted (HU) rats: comparison of the Sprague Dawley
vs. the Wistar Strains. Bars represent means +/- S.E.M. * indicates significantly
different from the control. P< 0.05. N=5.
2.5
T
2 i!ili! iiiii!t
T .:::::: _
J- :i:i:i:_:_:_:_:_:]
'°%'. ..... 4
','.'.:.:.:,:.:.:4
1.5 :':':';';'.';';'.1iiiii!..........._
..%°.
i:i:i:':':-:':':'l
o.s iiiiiiiiiiiiiiiiit
iiiiiiiiiiiiiiiii_
!iiiii!iiiiliiiil]
0 ;.:.:.;.;.;,;.;.;i
Sprague
Dawley
"I"
_%%%%%%%%
_%%%%%%%%
,%%%%%%%_
_%%%%%%%%
,%%%%%%%_
,%%%%%%%_
,%%%%%%%_
,%%%%%%%_
'%%%%%%%%
,%%%%%%%%
,%%%%%%%_
T ,%%%%%%%%
,%%%%%%%%
,%%%%%%%%
,%%%%%%%%
,%%%%%%%%
,%%%%%%%%
,%%%%%%%%
,%%%%%%%%
,%%%%%%%%
,%%%%%%%%
_%%%%%%%%
,%%%%%%%%
,%%%%%%%%
,%%%%%%%%
,%%%%%%%%
_%%%%%%%%
_%%%%%%%%
_%%%%%%%%
,%%%%%%%%
_%%%%%%%%
_,%%%%%%%%
_%%%%%%%%
,%%%%%%%%
_%%%%%%%%
_%%%%%%%%
_%%%%%%%%
_%%%%%%%%
_55555555
!
Wistar
[] HU AbdominalAorta
[] ControlAbdominalAorta
[] HU AbdominalAorta
[] ControlAbdominalAorta
Figure 2:
Vascular contractile responses to 68mM potassium in vessels from
control and twenty-day hindlimb (HU) Sprague Dawley rats. Bars
represent means +/- S.E.M.
P< 0.05. N=7.control.
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Figure 3:
Vascular contractile responses to 68mM potassium in vessels from
control and twenty-day hindlimb unweighted (HU) Wistar rats. Bars
represent means +/- S.E.M.
control. P< 0.05. N=6-4.
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Figure 4:
Vascular contractile responses to 68mM potassium in vessels from
control and fourteen-day hindlimb unweighted (HU) Sprague Dawley
rats. Bars respresents means +/- S.E.M. * indicates significantly
different from control. P< 0.05. N=3.
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Figure 5:
Vascular contractile responses to 68mM potassium in vessel from
control and fourteen-day hindlimbunweighted (HU) Wistar rats.
Bars represent means +/- S.E.M. * indicates significantly different
from control. P< 0.05. N=2-4.
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Figure 6:
Norepinephrine concentration-response curve for the contraction of the
abdominal aorta from control and twenty-day hindlimb unweighted (HU)
rats: comparison of the Sprague Dawley vs. the Wistar strains. Data are
presented as means +/- S.E.M. * indicates significantly different from the
control. P< 0.05. N--5.
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Figure 7:
Norepinephrine concentration-response curves for the contraction of the
carotid artery from control and twenty-day hindlimb unweighted (HU)
rats: comparison of the Sprague Dawley vs. the Wistar strains. Data are
presented as means +/- S.E.M. * indicates significantly different from the
control. P< 0.05. N=7-6.
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Figure 8:
Norepinephrine concentration-response curves for the contraction of the
femoral artery from control and twenty-day hindlimb unweighted (HU)
rats: comparison of the Sprague Dawley vs. the Wistar Strains. Data are
presented as means +/- S.E.M. * indicates significantly different from
control. P< 0.05. N=6-4.
1.5 - 1.5 -
Sprague Dawloy Wletar
_-_ 1.25- _ HUF_ItOnBARI_y _._ 1.25- _ HUFecnocIiARIty
t 1" + CA3111_1 '4tt'rltfY t 1" + C°ni_ F--II 'Atllry
Jo.Ts- . Jo. .
• o.s- ;--4L__-r _e o.s- _
0 _ 0- •
-0.251 , . i • i • i • i " , • I -0.25 , " i " , " , " , " i • I
-9 -8 -7 -e -5 -4 -3 -9 -8 -7 -6 -5 -4 -3
Norepinephrlne (Log M) Norepinq)hrine (Log M)
0.25 "
_ 0,15-
0.05-
-0.15
Figure 9:
Norepinephrine concentration-response curves for the contraction of the
jugular vein from control and twenty-day hindlimb unweighted (HU) rats:
comparison of the Sprague Dawley vs. the Wistar strains. Data are
presented as means +/- S.E.M.
control. P< 0.05. N=7-6.
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Figure 1O:
Norepinephrine concentration-response curves for the contraction of the
femoral vein from control and twenty-day hindlimb unweighted (HU) rats:
comparison of the Sprague Dawley vs. the Wistar strains. Data are
presented as means +/- S.E.M. P< 0.05. N=8-4.
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Figure 11 :
Norepinephrine concentration-response curves for the contraction of the
carotid artery from control and fourteen-day hindlimb unweighted (HU)
rats: comparison of the Sprague Dawley vs. the Wistar strains. Data are
presented as means +/- S.E.M. * indicates significantly different from
control. P< 0.05. N=2-3.
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Figure 12:
Norepinephrine concentration-response curves for the contraction of the
femoral artery from control and fourteen-day hindlimb unweightecl (HU)
rats: comparison of the Sprague Dawley vs. the Wistar strains. Data are
presented as means +/- $.E.M. * indicates significantly different from
control. P< 0.05. N--3-4
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Figure 13:
Norepinephrine concentration-response cureves for the contraction of
the jugular vein from control and fourteen-day hindlimb unweighted (HU)
rats: comparison of the Sprague Dawley strain vs. the Wistar strain. Data
are presented as means +/- S.E.M.
the control. P< 0.05. N=2-3.
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Figure 14:
Norepinephrine concentration-response curves for the contraction of the
femoral vein from control and fourteen-day hindlimb unweighted (HU)
rats: comparison of the Sprague Dawley vs. the Wistar strains. Data are
presented as means +/- S.E.M. * indicates significantly different from the
contrpl. P< 0.05. N=3-4.
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Figure 1 5:
Panel A: "
Vascular contractile responses to 68mM potassium during the perfusion
of the mesentary arteries from control and twenty-day hindlimb
unweighted (HU) rats: comparison of the Sprague Dawley vs. the Wistar
Strains. Bars represent means +/- S.E.M. * indicates significantly
different from the control. P< 0.05. N=9-5.
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Panel B:
Norepinephrine concentration-response curves for the contraction of the
mesentary artery during perfusion from control and twenty-day hindlimb
unweighted (HU) rats: comparison of the Sprague Dawley vs. the Wistar
strains. Data are presented as means +/- S.E.M. P< 0.05. N=9-5.
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Figure 16:
Serotonin concetration-response curves for the contraction of the
femoral =nd carotid arteries from control and twenty-day hindlimb
unweighted (HU) Sprague Dawley Rats. Data are presented as means +/-
$.E.M. * indicates significantly different from the control. P< 0.05. N=3.
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Figure 17:
Serotonin concentration-response curves for the contraction of the
jugular and femoral veins from control and twenty-day hindlimb
unweighted (HU) Sprague Dawley Rats. Data are presented as means +/-
S.E.M. * indicates significantly different from the control. P< 0.05. N=3.
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